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ABSTRACT 
Introduction: Irrational drug use remains globally common and there is a lack of country level synthesis for strategizing policy actions in Pakistan.  
Methodology: We conducted a scoping review of available peer reviewed and grey literature on prescribing patterns and drug dispensing in 
Pakistan to identify emerging concerns.  
Results: There is excessive drug use in Pakistan compared to the average for LMICs with inappropriate prescribing, high use of injections and 
antibiotics, choice of more expensive drugs, inadequate dispensing and weak community pharmacy. Policy concerns include excessive drug 
registration, poor enforcement of essential drug lists and standard management protocols, open access of industry to health providers, and lack of 
private sector regulation.  
Conclusion and Policy Recommendations: Review of evidence demonstrates deviance from rational use in the areas of medicine prescription, 
dispensing and self-medication, and low impact of existing policy measures. Quality of research needs to be improved focusing on standardized 
national surveys, consumer related formative research, and interventional research. 
Rational drug use is a neglected area in Pakistan requiring policy measures at multiple levels of health system and continued and simultaneous 
investment in standardized research.  
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INTRODUCTION 
Essential medicines, as defined by WHO, are those that satisfy the 
health care needs of the majority of the population [1]. The concept of 
“essential drugs”  was  introduced by WHO in 1975, followed by the 
first model Essential Drug List in 1977 and institutionalization of 
essential drugs as one of the eight components of primary health care 
in 1978 [2]. Irrational drug use is a common problem in Eastern 
Mediterranean and South Asian countries despite resource constraint 
for drugs [3; 4]. Irrational use may involve prescription of unnecessary 
number of medications, the use of injections where oral prescriptions 
are available, inadequate dosage or use over an inadequate period of 
time, use of antimicrobials for non-bacterial infection, the choice of 
higher cost over available lower cost therapeutic options, and 
inappropriate self- medication by patients [5].  
It is estimated that half of all medicines globally are inappropriately 
prescribed, dispensed or sold [6]. However much of the evidence is 
fragmented and there is a dearth of national level synthesis on 
rational drug use. Such synthesis is pertinent to promote effective 
policies, drug regulation, clear clinical guidance and patient 
awareness. We attempted to provide a synthesis of existing evidence 
on irrational prescriptions and dispensing in Pakistan. A scoping 
review was conducted to collate existing evidence on in Pakistan and 
identify emerging concerns. 
METHODS 
Our purpose was to landscape the evidence rather than a systematic 
sifting of evidence given that scientifically rigorous literature is thin 
in this area. The research was part of a larger exploratory study on 
Access to Medicines in Pakistan. The objective was to i) review 
existing literature relating to rational drug use; and ii) identify 
emerging policy concerns and research priorities. 
We conducted a desk review of electronic databases looking into 
peer reviewed and grey literature on the six parameters of irrational 
drug use as defined by WHO. A search was made on Pubmed, 
Cochrane, Cinahal WHOLIS, ELDIS and Google Scholar using MESH 
terms “Irrational drug use Pakistan”, “Drug dispensing Pakistan”, 
“Essential Drugs Pakistan” and “Injection use Pakistan”. Primary 
research and reviews supported by research data and published 
1990 onwards were included while bio-efficacy studies and 
commentary articles were excluded. Our search yielded a total of 
2176 titles from which 184 abstracts were shortlisted for review 
and 27 full texts were uploaded into EndNote (Figure 1). These 
comprised of 25 peer reviewed publications and 2 from grey 
literature. Yielded titles, abstracts and full texts were sifted by 2 
researchers for identification of relevant studies and information 
was extracted into thematic grids. Quality filters were not applied to 
studies retrieved.  
 
Fig. 1: Desk Review Process 
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The largest volume of literature was related to prescribing practices 
(n=20) while there was lesser data on rational dispensing and 
storage (n=5) and self-medications (n=4). Studies reported results 
from different regions of Pakistan and included findings from urban 
and rural areas. National large scale surveys were few with most 
studies having a local flavor and variation in sample from 25 to 3000 
recipients. Methodologies also tended to vary across the studies. We 
present here a summary of findings. Table 1 presents comparison of 
Pakistan specific data to averages for LMICs. 
 
Table 1:  Rational Drug Use Indicators: Comparison of Pakistan and LMIC 
Sr. No Pakistan Pakistan LMICs 
1.  Drugs per prescription 3 or >† 2.39† 
2.  Drugs per prescription public sector 2.77≠  
3.  Drugs per prescription private sector  4.51*  
4.  Antibiotics prescribed per patient encounter 70%†/ 52%≠ 45%† 
5.  Injections prescribed per patient encounter 60%†/14.7%≠ 23%† 
6.  Medicines prescribed from formulary 50%π 71.7 % 
7.  Facilities having national formulary 20%≠ 78%† 
8.  Medications prescribed by brand names 88%* 40%† 
9.  Mean dispensing time 38 sec# 105 sec† 
10.  Mean consultation time  1.8-9 minutes#  4 minutes † 
11.  Self-medication of antibiotics 6-11%‡  
Source: † WHO: The World Medicines Situation; 2004. 
≠Networks: EDSP Baseline Survey Report; 2002. 
*Das N, Prescribing practices of consultants at Karachi, Pakistan.2001 
†WHO: The World Medicines Situation; 2004. / ≠Networks: EDSP Baseline Survey Report; 2002 
π Das N, Prescribing practices of consultants at Karachi, Pakistan. 2001, Najmi:Prescribing practices: an overview of three teaching hospitals in 
Pakistan. 1998,  
#Hafeez A, Prescription and dispensing practices in public sector health facilities in Pakistan: 2004, Network: EDSP Baseline Survey Report; 2002 
‡Haider & Thaver: implication for primary health care strategies. 1995, Sturm: Over-the-counter availability of antimicrobial agents, self-medication 
and patterns of resistance in Karachi, Pakistan. 1997 
#Hafeez A: Prescription and dispensing practices in public sector health facilities in Pakistan: 2004, Nizami SQ,: Drug prescribing practices of 
general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan. 1996, / Networks: EDSP Baseline Survey Report; 2002. 
 
Excessive prescription of drugs 
The average number of drugs prescribed per patient is 3 or more in 
Pakistan as compared to an average of 2-3 in LMICs [5] (Table 1). 
The use of medicine is significantly higher in private sector with an 
average of 4.1 medicines per prescription as compared to 2.7 in 
public sector (p<0.001)[7]. Similar results are reported by other 
studies with an average of 4.5 for private sector [8] and 2.77 for 
public sector [9], and would be even higher in both sectors if drugs 
per patient were computed. Within the public sector, there is little 
difference between medicines per prescription at frontline health 
facilities (2.75) and Teaching Hospitals (2.79)[10] underscoring the 
need for efficiency in prescriptions at frontline health facilities. 
Although a National Essential Drug List (EDL) exists, its availability 
was seen in one out of five public sector facilities [9]. The 
Compliance of medicines prescribed with EDL is reported to be only 
50% in private sector [8] but is relatively higher at 80% in public 
sector teaching hospitals [11].  
Antibiotic overuse 
Antibiotic overuse is one of the main reasons for excessive 
prescription with antibiotics prescribed in 70% of patient 
encounters in Pakistan as compared to 45% in LMICs [5].  
Prescription rate is significantly higher for antibiotics (62%) and 
injections (48%) amongst GPs as compared to public sector with 
rates of 54% and 22% respectively (p < 0.001) [7]. Even within the 
public sector there is tendency to prescribe more costly antibiotics.  
A study reported 70% of prescriptions bypassing lower cost 
antibiotic alternatives at teaching hospitals [12] and another study 
reported use of 3rd generation (28%) and 1st generation (24%) 
Cephalosporins as leading antibiotics for surgical procedures with 
least use of macrolides [13]. 
Excessive use of injections 
Pakistan has one of the highest rate of injection usage with over 60% 
patient encounters involving an injection as compared to 60% in 
LMICs [5]. Studies have reported up to 57% of patient encounters 
involving injections in public sector [12] and 25% in private sector 
[8]. Use of intravenous infusions is also significantly high in the 
private sector with 11% of GP prescriptions involving intravenous 
infusion compared with 1% for public providers (p < 0.001) [7]. 
Preference for injection usage is higher amongst general 
practitioners in rural areas (53%) as compared to urban areas 
(28%) while safe injection handling and disposal practices are 
weaker in rural areas [14; 15]. Insufficient quantities of syringes, use 
of multi dose vials for medications and lack of disposal boxes have 
been reported from health facilities leading to risky usage [16]. 
Inappropriate use - communicable diseases 
Prescription practices even for common endemic diseases 
frequently deviate from standard protocols. Treatment pattern for 
upper respiratory tract infections showed antibiotics being 
prescribed in an alarming 89% of prescriptions despite most such 
infections being self-limiting in nature [17]. Analysis of childhood 
diarrhea management showed that there was sub-optimal 
prescription of ORS and overuse of antibiotics. Only 53% of GPs and 
61% of specialists prescribed ORS in more than 50% of encounters, 
while 50% of GPs and 66% of specialists prescribed antimicrobials 
with interestingly no significant difference between GPs and 
specialist [18]. Another study comparing across the public and 
private sectors showed GPs prescribing anti-diarrheals more 
frequently than doctors working in the public sector (p < 0.01). 
Management of tuberculosis also showed frequent variation from 
the recommended treatment. Only 3.4% GPs had knowledge of all 
DOTS components, 35% able to correctly prescribe drugs, dose and 
duration for initial phase and 30% for continuation phase of the 
therapy [19; 20]  
Inappropriate use - non communicable diseases 
Drug prescribing patterns for chronic diseases also need significant 
rationalization. Appropriate therapy for hypertension is initiated by 
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only 35% of practitioners, thiazide diuretics internationally 
recommended as first line regimen are rarely prescribed (4.2%) and 
sedatives commonly used either as first-line medication for lowering 
BP (23.8%) or in combination with antihypertensive agents (45%) 
[21]. A study on diabetes management reports that insulin therapy 
was advised in combination with gluco-corticosteriods, thiazide 
diuretics, and propranolol, which are contraindicated due to drug 
interactions [22]. Yet another study on mental health reports that 
the treatment for psychiatric illnesses did not correlate to diagnosis 
in 25% of cases and doses of drugs were inappropriate in 31% 
prescriptions [11]. Overuse of steroids has been reported for 
arthritis and fairly high proportion of patients (38%) reported side 
effects [23]. 
Drug Dispensing and Storage 
Provision of patient information needs improvement across health 
care providers and dispensers. Survey of public sector facilities 
found mean consultation time of only 1.79 minutes insufficient to 
give proper advice on medicine usage [10]. Lengthier times have 
been reported in private sector however yet insufficient for proper 
advice. Mean consultation time of 3 minutes by GPs and 9 minutes 
by pediatricians was reported for childhood diarrhea with 
instruction for ORS use was given in only 6% of encounters by GPs 
and 8.4% of encounters by pediatricians [18]. Dispensing time in the 
public sector has been reported as 38 seconds across a range of 
facilities, none of the dispensers wore gloves while dispensing, only 
11% of drugs dispensed were adequately labeled and only 12% of 
cases a duplicate record of prescription was maintained at health 
facility [10]. Manual for procedures was available in only 5% of 
public sector facilities, refrigerators were working in 60% and 
temperature control was present in 24% [19].  
Community Pharmacies 
There are 45000-50000 pharmacies and medical stores in Pakistan 
[24], one of the highest numbers in LMICs. The large number of drug  
outlets makes regulatory checks difficult. A survey of drug outlets 
shows that only 12% of drug dispensers were pharmacologically 
trained and merely 35% had secondary school qualification [25]. 
Knowledge of correct dosages for common infections was poor with 
only 24% knowing proper administration of ORS, 21% suggesting 
anti-diarrheal preparation for childhood diarrhea, and 60% knowing 
the correct dose for amoxicillin [25]. Existing regulatory checks are 
aimed at quality of drug products but there is little regulation of 
quality of retail outlet. Proportion of pharmacies meeting licensing 
requirements was only 19.3%, qualified staff was present in only 
22% pharmacies, only 10% had a temperature monitoring device 
and 4% had back-up power supply for refrigerators against frequent 
power outages [24]. 
Self-Prescription 
Self-medication is reportedly widespread in Pakistan, however there 
are few studies that capture the magnitude of self-medication. In a 
household survey examining health seeking behavior for childhood 
illnesses, self-medication with antibiotics was seen in 11%of cases 
and with anti-diarrheals and anti-emetics in 11% of cases (11%) 
[26]. Another household survey within the general population found 
6% rate of antibiotic self- medication [27]. However these figures 
are nearly two decades old and require updating. Self-medication is 
also common amongst the youth. A study on college students found a 
third of non-medical students reporting self-medication and 55.3% 
of medical students mostly belonging to 1st and 3rd year of medical 
college prescribe medicines independently [28;29].  
Branded Use and Marketing Issues 
88% of medicines are prescribed by brand names that in Pakistan 
[8] as compared to an average of 40% in LMICs [5]. Attending 
sponsored CME events and accepting funding for travel for 
educational symposia was associated with increased prescription 
rates of the sponsor's medications [30]. Another study critically 
analyzing claims from drug promotional brochures showed that 
18% of advertisements were unjustifiable of which 32% was 
exaggerated, 21% ambiguous, 26% false and 21% controversial [31]. 
Yet another study reported that only 26% request information 
provided in educational brochures only received a response and 
only 15% of responses met the WHO criteria for optimal drug 
information [32].  
DISCUSSION 
Irrational drug use has been highlighted as a serious concern across 
LMICs but there is a dearth of national level synthesis [5]. We 
attempted to collate evidence on rational drug use in Pakistan by 
conducting a review of available published and grey literature on 
extent of the problem in Pakistan. Our focus was on rational use 
including prescriptions, dispensing, storage and patient usage of 
medicines. We did not report on availability issues which are the 
subject of a related larger study on access to medicines. 
Although an Essential Medicines Program was established in 
Pakistan in the 1970s, our review indicates that irrational use 
continues to be widely prevalent. Prescription of medicines and 
injections is higher in Pakistan compared to the average for LMICs, 
mainly driven up high level of antibiotic usage.  As shown in table 1, 
average number of medicines prescribed per prescription is 3 or 
more in Pakistan and some studies indicate it to be 4.5 in private 
sector. Whereas on contrary a study conducted in Chennai, India at a 
tertiary care hospital on antibiotics use concluded that average of 
2.07 (Mean ± SD 2.07±0.9) drugs were prescribed per prescription 
[33].  
Prescription Medicines are inappropriately prescribed even for 
endemic diseases despite existence of national disease control 
program and standard management protocols. Even though a 
national essential drug list exists, compliance with it is low across 
the sector. Prescribing predominantly follows brand names, and low 
cost options are frequently overlooked in favor of costlier medicines 
even in public sector facilities. Mean consultation time and medicine 
dispensation time is insufficient for patient advice on usage 
medicines, and safety and storage parameters for dispensing are 
inadequate. Irrational use is more marked in the private sector and 
in rural areas. Community pharmacy is also weak with under-
equipped drug outlets, excessive access to over the counter drugs 
and insufficient attention to safety measures during dispensing. 
Evidence suggests that self-medication with antibiotics is commonly 
practices by 6-11% of the population. Prescribing related and 
community usage issues relate to irrational use have been 
highlighted by recent studies from India, Iran, Lebanon, Lao and 
Thailand [4; 3; 34; 35]. 
Implications of excessive inappropriate drug use in Pakistan are 
already evident in Pakistan. Medicines consume the largest share 
(56%) of household out-of-pocket payments [36] and are driven up 
by excessive prescriptions and brand medications in addition to 
supply and pricing issues. Population based resistance to frontline 
antibiotics including ampicillin, cotrimoxazole, chloramphenicol and 
erythromycin was documented nearly two decades ago [27] and 
there is high incidence of multi-drug resistance-TB strains in 
Pakistan [37]. Moreover, overuse of injections has been conclusively 
linked to relatively high burden of Hepatitis B and C infection in 
Pakistan [38].  
Policy measures globally have typically focused on the essential drug 
list and standard management guidelines and with a concentration 
on the public sector, overlooking the private sector [39]. In Pakistan, 
policy concerns (Figure 2) need to go be wider to address 
contributors of irrational drug use in with integrated action at 
multiple tiers of the health system. First, there is excessive 
registration of drugs in Pakistan with approximately 50,000 
registered drugs [40], one of the highest numbers in LMICs. Many of 
the registered products are unnecessary, being variations in brand 
names and dosages. Although detailed procedures exist for drug 
product registration [41] weak adherence has encouraged a market 
monopoly with loose control [42]. De-registration is rare and even 
when applied its impact has been diluted by black marketing 
channels and continued physician prescriptions [43]. Second, while 
a national essential drug list has been in place since 1994 [40] and 
standard protocols of management are well developed, attention is 
needed on better enforcement strategies. Third, the private sector, 
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which has higher levels of inappropriate use and is the major 
provider of care, is poorly regulated and has few opportunities for 
government supported continuous medical education. Quackery is 
reported to be widespread but there is lack of database 
differentiating between licensed and un-licensed providers. Fourth, 
inappropriate advertisement claims and unrestricted access to 
medical practitioners have been linked with irrational prescribing. 
The Pakistan Medical and Dental Council’s ordinance on relationship 
between the industry and registered doctors and dentists is vague at 
best [44]. Finally, weak community pharmacy with proliferation of 
sub-standard drug outlets and largely unrestricted access to over the 
counter drugs further compounds the problem. These policy 
concerns need to be holistically addressed across pharmaceutical 
policy as well as health systems reforms. 
 
Fig. 2: Priority Policy and Research Concerns: 
Policy Concerns Research Concerns 
Adherence to EDL and standard management protocols Periodic surveys of providers and drug outlets 
Patient instructions, dispensing and storage of drugs Reporting on standardized methods and indicators 
Brand name prescriptions and unrestricted access of industry to providers Differentiating licensed from unlicensed providers 
Regulation of drugs retail outlets Consumer demand and accountability 
Self medication and unrestricted access to drugs Best practice lessons from interventional research 
 
Methodological challenges also need to be systematically addressed 
for rational drug use (Figure 2). While there were a number of 
studies on irrational use these generally lacked standardization, 
were local rather than national in scope and needed regular update. 
Efforts need to be directed towards development of national 
standard standardized databases to monitor rational drug 
consumption involving periodic drug surveys across health facilities, 
community pharmacies and communities, as practiced in established 
economies [45]. This argument is in line with findings in a study on 
antibiotic therapy for pneumonia in a rural healthcare center in 
India, where it was found that 
the  present  guidelines  in  standard  textbooks for the treatment of 
pneumonia was giving a  varied range of guidelines for treating 
in Out Patient Department   basis and for treatment in the ward. This 
phenomenon is exposing unnecessarily mild cases of pneumonia to 
the similar treatment as given in severe case [46 ].  
International indicators, standards and methodologies to provide 
benchmarks across countries are available developed by the 
International Working Group for Drug Statistics Methodology and 
the International Network for the Rational Use of Drugs [47; 48]. 
Supplementary research is also required in mapping of private 
sector inclusive of qualified providers, informal providers, and 
shadow pharmacies. These need to be accompanied by formative 
research looking into consumer demand, health-seeking 
preferences, and patient accountability which has been less well 
explored in comparison to quantitative concerns. Finally, there is 
less published in terms of successful interventions [39] and 
compilation of lessons learnt is needed for promotion of rational use 
at policy, supply, provider and consumer levels.  
While rational drug use is an old agenda in Pakistan amongst the 
academic circles, policy and programmatic enforcement measures as 
well research rigour needs strengthening. Integration is needed across 
health systems and pharmaceutical policy research at all levels.  
CONCLUSION 
A collation of existing evidence in Pakistan shows deviation from 
rational use across medicine prescription, dispensing and self-
medication, and low impact of existing policy measures. Policy 
investment is needed in regulation of drugs to reduce unnecessary 
proliferation and prescribing, and strengthening quality parameters 
at provider and community pharmacy. Investment is also needed in 
standardized surveys on rational use, formative research on 
consumer demand, and collation of successes policy ventures.  
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